Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Matrix Asset Advisors is a 100% employee-owned investment advisory and asset management firm founded in 1986. The company specializes in value-driven equity and fixed income portfolio management for individuals, families, endowments, foundations, and retirement plans. It manages U.S. equities through high-conviction portfolios of large and mid-cap companies using a disciplined value-oriented approach rooted in Graham and Dodd principles. As of March 2022, the firm managed approximately $971 million in assets. The company does not operate within the life sciences/biotech/pharma/healthcare sector. Its investment strategies include separately managed accounts with optional ESG overlays as well as no-load mutual funds. Key holdings often include major public companies across various sectors (e.g., Microsoft Corporation, Medtronic Plc). There are no clinical results or drug development activities associated with this company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Matrix Asset Advisors.